Product Information
CLONAZEPAM 0.5 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0199 per EA under NDC 16729013600. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
.5 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729013600
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077147On Market Since
6/3/2011
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.5 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 21.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0199 per EA |
|---|---|
| All-time high | $0.0302 (Jul 12, 2023) |
| All-time low | $0.0154 (Jan 18, 2017) |
| 52-week high | $0.0224 |
| 52-week low | $0.0198 |
| Median price | $0.0211 |
| Average price | $0.0212 |
| Largest weekly change | -34.1% (Nov 20, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.5 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0199 per EA (NDC 16729013600), effective Jun 24, 2026.
How has the price of CLONAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.5 MG TABLET has risen 21.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.5 MG TABLET?
Since Nov 28, 2013, the NADAC for CLONAZEPAM 0.5 MG TABLET has ranged from a low of $0.0154 (Jan 18, 2017) to a high of $0.0302 (Jul 12, 2023), with a median of $0.0211 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.5 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as CLONAZEPAM 0.5 MG TABLET, but none are currently priced below it.
Who manufactures CLONAZEPAM 0.5 MG TABLET?
CLONAZEPAM 0.5 MG TABLET (NDC 16729013600) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification